Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluation of an artificial intelligence-based clinical trial matching system in Chinese patients with hepatocellular carcinoma: a retrospective study
11
Zitationen
9
Autoren
2024
Jahr
Abstract
We found that the CTMS is particularly reliable in excluding ineligible patients in a significantly reduced amount of time. The CTMS excluded ineligible patients for clinical trials with good performance, reducing 98.7% of the work time. Thus, such AI-based systems with natural language processing and machine learning have potential utility in Chinese clinical trials.
Ähnliche Arbeiten
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
2003 · 10.819 Zit.
Estimating the mean and variance from the median, range, and the size of a sample
2005 · 8.959 Zit.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 · 6.964 Zit.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
2020 · 5.272 Zit.
The global landscape of AI ethics guidelines
2019 · 4.582 Zit.